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Abstract
Background: Sequential injection chromatography (SIC) is a new alternative separation technology. It has some
advantages over high performance liquid chromatography (HPLC) regarding simplicity, inexpensiveness, portability,
ease of use, maintenance requirement and operation time. In contrast, SIC has had suffered from some limitations.
Results: The current work involves four achievements. (a) One of the limitations of SIC has been overcome. A
higher pressure resistant selection valve with additional ports was installed in an SIC system. This development
allows propelling solution without showing solution leakage. (b) A new inexpensive rapid and green method for
the separation and quantification of propranolol (PRP) and hydrochlorothiazide (HTZ) in their formulations was
optimized and validated. (c) A miniaturized multi-channel fiber optic detector was coupled with the newly
developed SIC system to detect PRP and HTZ at 270 and 290 nm, respectively. This issue enhanced the sensitivity
rather than using a single-channel detector. (d) A comparative study on the efficiency of the SIC method with that
of previous HPLC methods was conducted.
Conclusions: Besides the benefits of the instrumentation of SIC, the proposed method is rapider and more
reagent-saving than previous HPLC methods. The total volume of consumed reagents and sample was 4.04 mL.
The sample frequency was 22 samples/h. Other such analytical characters of the SIC method as resolution, peak
symmetry, numbers of theoretical plates, linearity range, accuracy, precision and limits of detection and
quantification recorded comparable results.
Background
Despite its limitations, conventional high performance
liquid chromatography (HPLC) is still the dominant
technique in pharmaceutical analysis. Conventional
HPLC instrumentation has suffered from such chal-
lenges as long analysis time, large consumption of sol-
vents and reagents, high cost, complicated routine
maintenance, ease of use and large dimension.
Flow injection (FI) techniques have been well-devel-
oped with the advantages of automation, miniaturiza-
tion, versatility, simplicity and inexpensiveness. The
family of FI techniques includes three generations and
some versions [1,2]. Sequential injection analysis (SIA),
as the second generation, is the most effective technique
[3-13]. SIA applies a miniaturized, fully-automated, bi-
directional, discontinuous, precisely-choreographed and
flow procedure. Nevertheless, implementing separation
procedures with multi-analyte quantification in FI tech-
niques was a challenge.
The advent of monolithic columns has facilitated the
combination of chromatography with FI techniques, par-
ticularly SIA. The joint use of SIA and monolithic col-
umns has provided sequential injection chromatography
(SIC) [14]. The bimodal pore structure of monolithic col-
umns, i.e. macro- and mesopores, allows higher perfor-
mance separation at higher flow rates than those applied
in particle columns. The instrumentation of SIC has
some advantages over that of HPLC. The remarkable
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© 2010 Idris et albenefits of SIC are simplicity, inexpensiveness, portabil-
ity, ease of use and less cost of routine maintenance. In
addition, unlike HPLC, SIC applies a miniaturized dis-
continuous flow-based procedure. Hence, SIC is more
reagent-saving than HPLC. This feature does not only
render SIC methods inexpensive, but also provides better
safety for the environment. In contrast, SIC has suffered
from some drawbacks. The selection valve (SV) in com-
mercially available SIC systems has a limited pressure tol-
erance, which is 250 psi. This drawback causes the
problem of solution leakage especially when applying
high flow rates, adopting a mobile phase including a buf-
fer or installing long monolithic columns. Another draw-
b a c ko fS I Ci st h a tt h es y r i n g ep u m p( S P )h a sl i m i t e d
flow rates, which is due to the maximum back pressure,
which is about 2.5-3.0 MPa. Additionally, the SP has so
far a limited volume; the commercially available maxi-
mum volume is 4 mL. Furthermore, sufficient software
has not been developed yet for data interpretation.
Despite all theses drawbacks, SIC has been successfully
applied to pharmaceutical analysis [15,16].
Propranolol hydrochloride (PRP) is a beta-blocker
drug that is widely used in the treatment of angina pec-
toris, cardiac arrhythmias and hypertension [17]. PRP is
chemically named 2- propranolol,1-[(1-methylethyl)
amino]-3-(1-naphthalenyoxy)-,hydrochloride, (±)- or
(±)-1-(Isopropyl amino)-3-(1-napthyloxy)-2-propranol
hydrochloride (Figure 1a). On the other hand, hydro-
chlorothiazide (HTZ) is a widely used thiazide diuretic
agent. It is used for the treatment of both diuretic and
hypertensive clinical indications [18]. HTZ is chemically
named 6-chloro-3, 4-dihydro-7-sulfamoyl-2H-1, 2, 4-
bezothiadiazine 1,1-dioxide, 6-chloro-3, 4-dihydro-2H-1,
2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide,6-
chloro-7-sulfamyl-3, 4-dihydro-1, 2, 4 - benzothiadiazine
1,1-dioxide,2H-1, 2, 4-benzothiadiazine-7-sulfonamide,
6-chloro-3, 4-dihydro-1, 1-dioxide (Figure 1b). The use
of diuretics such as HTZ with beta blockers such as
PRP has been advocated as the first line therapy for the
treatment of hypertension in many countries. PRP and
HTZ have been used in combination to provide an
enhanced therapeutic effect than when either a drug is
used alone [19].
Using the Scopus
® and Science Citation Index
® data-
bases, it has been found that few methods for the
separation and simultaneous quantification of PRP and
HTZ are available in the literature. In this issue, HPLC
[20-22], thin layer chromatographic [23] and spectro-
photometric methods [21,24] were reported.
The main objectives of the current work are: (a) to
replace a lower pressure SV with less ports installed in
commercially available SIC systems by a higher pressure
SV with additional ports, (b) to develop a new competi-
tor SIC method to previous HPLC methods for the
separation and quantification of PRP and HTZ in their
formulations, (c) to improve the sensitivity of the pro-
posed method by coupling a miniaturized multi-channel
detector with the newly developed SIC system and (d)
to illustrate the advantages of SIC over HPLC through-
out a comparative study.
Results and discussion
SIC development
In the current work, a higher pressure resistant SV,
which is used in HPLC systems, was installed in an SIC
assembly. The pressure tolerance of the new SV was
5000 psi while that of the past SV was 250 psi. This
development permitted efficient solution flow without
showing solution leakage. The new SV has another
advantage that includes 10 ports, which allow connect-
ing more solutions. As shown in Figure 2, three stan-
dard solutions and five samples were attached
simultaneously and analyzed in a one-shot run.
Method optimization
Primarily, spectrum scans were carried for PRP and
HTZ. It has been found that the lmax for PRP and HTZ
were 270 and 290 nm, respectively. On the other hand,
no need for internal standard since a simple procedure
for sample treatment was applied. Additionally, peak
height was adopted instead of peak area because sharp
peaks were obtained.
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Figure 1 Chemical structure of (a) PRP and (b) HTZ.
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monolithic column has found to be suitable. For opti-
mizing flow rate, the range of 10-40 μL/s has found to
be practicable in SIC procedures based on column
length and mobile phase composition [16]. With
respect to peak height and peak shape, the practicable
r a n g eo fs a m p l ev o l u m eh a sf o u n dt ob e1 0 - 4 0μL
[16]. At high flow rate, rapid elution and high peaks
with insufficient separation were obtained. Peaks were
also heightened by injecting large sample volumes.
However, symmetrical peaks were not obtained. There-
f o r e ,t oc o m p r o m i s eb e t w e e np e a kh e i g h t ,p e a ks h a p e
and analysis time, 40 μL/s flow rate and 30 μL sample
volume were set as the optimum. For mobile phase
composition, two systems were examined including 50
mmol/L phosphate:acetonitrile (85: 15, v/v) at pH 3.0
[20] and 75 mmol/L phosphate:acetonitrile (70:30, v/v)
at pH 3.0 [22]. In the current study, the second mobile
phase composition performed sufficient separation
with acceptable peaks.
Method validation and comparative study
The proposed SIC method was validated under the opti-
mized conditions according to the guidelines of the
main regulatory agencies, namely International Confer-
ence on Harmonization (ICH) of Technical Require-
ments for Registration of Pharmaceuticals for Human
Use [25] and the International Union of Pure and
Applied Chemistry (IUPAC) [26]. Furthermore, a com-
parative study on analytical features of the SIC method
with those of previous HPLC methods [20,22] was con-
ducted. All available experimental conditions and
analytical features of the SIC and HPLC methods are
introduced in Table 1.
Separation efficiency
Under the optimized conditions, resolution (R), numbers
of theoretical plates (N) and peak symmetry (PS) were
calculated using equations 1-3, respectively. “tR“ is a
retention time. “wb“ is the peak width at the base. “Af“ is
t h ea r e ao faf r o n tp e a k .“At“ is the area of a back peak.
“w0.5“ is the peak width at a half height.
R =
2(tR2 − tR1)
wb1 + wb2
(1)
PS =
Af
At
(2)
N =1 6

tR
w0.5
2
(3)
PRP and HTZ were sufficiently separated (with a resolu-
tion of 3.6 and the number of theoretical plates of > 4200)
in a short time. In a previous HPLC method [22], higher
resolution, i.e. namely 8.9, was due to the use of a longer
separation column (4.6 × 150 mm). In another HPLC
method [20], much higher resolution, i.e. namely 12.1,
could be attributed to stationary and/or mobile phases
that were/was applied. Despite a shorter C18 monolithic
column was adopted in the current SIC method, satisfac-
tory separation, with a resolution of 3.6, was achieved. In
addition, comparable peak symmetry and numbers of the-
oretical plates were achieved in the SIC and HPLC
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Figure 2 Schematic diagram of a sequential injection chromatograph constructed for the separation and quantification of PRP and
HTZ.
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Page 3 of 8methods. It is interesting to note that despite a slower flow
rate in the SIC method than that in the previous HPLC
methods was applied, a shorter retention time was
obtained in the frontal method. This benefit could be
attributed to the use of a short monolithic column.
Linearity
Several standard solutions of PRP and HTZ were subjected
to SIC analysis. Figure 3 shows a typical chromatogram of
four replicates of three standard solutions including PRP
and HTZ. Satisfactory linearity of both drugs was
obtained in the SIC method, which is comparable with
that of the previous HPLC methods (Table 1) [20,22].
Precision
The intra-day precision was evaluated by analyzing three
solutions obtained from tablets. Three concentrations of
PRP and HTZ were applied. Each sample was sequen-
tially analyzed seven times a day. Similarly, the inter-day
precision was evaluated by analyzing the same samples
in five consecutive days. The RSD of retention times
and peak heights of PRP and HTZ were calculated. In
general, as shown in Table 1, acceptable intra-day preci-
sion with RSD values of less than 1.0 was obtained from
the SIC method and a previous HPLC method [20].
Limits of detection and quantification
The limit of detection (LOD) was examined as the con-
centration of a solute resulting in a peak height three
times the baseline noise level. The limit of quantification
(LOQ) was examined as the concentration of a solute
resulting in a peak height ten times the baseline noise
level. Table 1 shows that the SIC method has acceptable
LOD and LOQ for both drugs in their formulations,
which are comparable with those of a previous HPLC
method [22]. It is worth noting that the sensitivity of
the SIC method was enhanced by using a short column,
a large sample volume, a high flow rate and a multi-
channel detector. For example, as shown in Figure 3,
the standard solution including 25 μg/mL HTZ recorded
0.15 AU at 290 nm and 0.38 AU at 270 nm.
Reagent consumption and analysis time
Besides the benefits of the instrumentation of SIC dis-
cussed before, the proposed SIC method has further
advantages over the previous HPLC methods [20,22]. SIC
applies a miniaturized discontinuous flow-based proce-
dure. Therefore, the proposed SIC method is more
reagent- and time-saving. The total volume of the con-
sumed mobile phase including column conditioning in the
SIC method was 4.0 mL. The total analysis time in the SIC
method was 165 s (Table 1) while that in a previous HPLC
method [22] was more than 1200 s. Hence, the sample fre-
quency of the SIC method was 21 samples/h.
Applications
T h ep r o p o s e dS I Cm e t h o dw a sa p p l i e dt ot a b l e tf o r m u -
lation with different doses of PRP and HTZ in combina-
tion and single forms (Figure 4). Each sample was
applied in triplicate. To examine the reliability of the
Table 1 Comparison of some conditions and features of the SIC method with previous HPLC methods
Condition SIC HPLC [20] HPLC [22]
Separation column C18 (4.6 × 50 mm) CPS
a (4.6 × 25 mm) C18 (4.6 × 150 mm)
Mobile phase composition 75 mmol/L PHS:ACN
b (70:30, v/v) at pH 3.0 50 mmol/L PHS:ACN
(85:15, v/v) at pH 3.0
75 mmol/L PHS:ACN (70:30, v/v) at
pH 3.0
Consumed mobile phase volume (mL) 4 < 10 -
Sample volume (μL) 40 20 20
Waste production volume (mL) 4 10 -
Flow rate (mL/min) 1.8 2.0 1.2
Analysis time (s) 165 < 1200 -
Resolution 3.6 12.1 8.9
HTZ PRP HTZ PRP HTZ PRP
UV detection (nm) 270 290 290 290 274 290
Retention time (s) 0.7 1.0 4.5 14.2 2.2 5.7
Peak symmetry 1.10 1.50 - - 0.98 0.57
Theoretical plates 4203 88671 8962 8962 172 385
Calibration equation PH
c = 0.0231C
d+0.0398 PH = 0.0028C+0.095 - - PH = 0.022C
+0.0144
PH = 0.0129C+0.0283
Correlation coefficient 0.9999 0.9989 1.0000 0.9993 0.9995 0.9990
Recovery (%) 97.0-100.5 94.0-104.9 98.0-100.4 97.8-100.3 - -
Linear range (μg/mL) 5-50 25-200 10-92 16-160 1-70 2-40
LOD (μg/mL) 0.6 1.0 - - 0.6 0.3
LOQ (μg/mL) 2.0 3.4 - - 2.0 1.0
Repeatability (RSD %) 0.77 0.40 0.30 0.70 - -
a: Cyanopropylsilane; b: phosphate:acetonitrile; c: peak height; d: concentration (μg/mL).
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to HPLC analysis using a previous procedure [22]. The
average of triplicate measurements was calculated. The
results obtained are introduced in Table 2. The recovery
was in the range of 100.5 - 95.7%, which indicates
acceptable reliability of the SIC method.
Experimental
Instrumentation
The following devices were used to construct an SIC
assembly (Figure 2).
i. S17 PDP
® Syringe pump (SP) with a reservoir of 4
mL was manufactured by Sapphire Engineering
(Pocasset, MA, USA).
ii. 10T-0179H Cheminert
® high-pressure stainless-
steel selection valve (up to 5000 psi) with 10 ports
was manufactured by Valco Instrument Co. (Hous-
ton, TX, USA).
iii. USB-4000
® fiber optic CCD UV/Vis detector and
DH-2000
® deuterium UV light source were manu-
factured by Ocean Optics Inc. (Dunedin, FL, USA).
iv. Ultem
® 10 mm micro-volume Z-flow cell was
supplied from FIAlab Instruments Inc. (Bellevue,
WA, USA).
v. 200 micron sub-miniature version A
® fiber optic
connectors with a core diameter of 600 μmw e r e
supplied from CeramOptec (East Longmeadow, MA,
USA).
vi. Pump tubing of 0.03” I.D. Teflon type was sup-
plied from Upchurch Scientific, Inc. (Oak Harbor,
WA, USA). It was used to connect various devices
in the SIC system and to make a holing coil (200 cm
long).
vii. Chromolith
® reversed-phase monolithic column
(4.6 × 50 mm) and monolithic guard column (4.6 ×
5 mm) were manufactured by Merck (Darmstadt,
Germany).
viii. PC equipped with FIALab Software
® for Win-
dows
® version 5.9 was supplied from FIAlab (Med-
ina, WA, USA). It was used for programming and
controlling the SIC system.
Reagents and chemicals
All chemicals and reagents used in the current study
were of analytical grade quality. Distilled deionized
water was used throughout. Methanol, acetonitrile, diso-
dium hydrogen phosphate, PRP and HTZ were supplied
from Sigma-Aldrich (Taufkirchen, Germany).
Figure 3 Sequential injection chromatogram for four replicate measurements of 5, 25 and 50 μg/mL HTZ and 25, 100 and 200 μg/mL
PRP for calibration purpose. Optimum conditions: C18 monolithic column (4.6 × 50 mm), a mobile phase composition of 75 mmol/L
phosphate:acetonitrile (70:30, v/v) at pH 3.0, flow rate 30 μL/s, sample volume 40 μL, UV detection at 270 nm for HTZ and 290 nm for PRP.
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Mixed standard solution of PRP and HTZ (1000 μg/mL)
was prepared by dissolving appropriate amounts directly
in water. Working standard solutions were prepared by
dilutions in appropriate ways.
For sample preparation, twenty tablets of each sample
were accurately weighed and powdered. Water was
added to appropriate amounts of powder to extract PRP
and HTZ. The obtained solutions were filtered through
Whatmann
® filter papers number one. Thereafter, the
dilution was conducted in an appropriate way to obtain
different concentrations. In general, all solutions were
filtered through 0.45 μm membrane before injecting to
an SIC system.
SIC procedure
As shown in Figure 2, mobile phase was linked with the
check valve that is positioned at the front of the SP
head. Waste was disposed through port-1. Guard col-
umn, separation column and Z were linked with port 2.
Standard solutions were linked with port-3 to 5. Sample
solutions were linked with port-6 to 10. A holding coil
was installed between the central valve in SV and a port
in the SP head. The relief valve was linked with a port
at the bottom of the SP head. A rapid protocol control-
ling the proposed SIC procedure was programmed as
illustrated in Table 3.
Conclusions
In the current study, an SIC assembly was developed. A
SV, with a higher pressure tolerance and additional
ports, was installed in an SIC assembly. The new SV
solved the problem of solution leakage especially when
applying a high flow rate for propelling a mobile phase
that includes a buffer. The additional ports permitted
the analysis of eight samples with a one-shot. On the
Figure 4 Sequential injection chromatogram for duplicate measurements of: (a) 25 μg/mL HTZ and 40 μg/mL PRP extracted from
Inderide
® tablets; (b) 40 μg/mL PRP extracted from Ciplar LA
® tablets, (c) 25 μg/mL HTZ and 80 μg/mL PRP extracted from Inderide
®
tablets and (d) 25 μg/mL HTZ extracted from Lannett
® tablets. Optimum conditions: C18 monolithic column (4.6 × 50 mm), a mobile phase
composition of 75 mmol/L phosphate:acetonitrile (70:30, v/v) at pH 3.0, flow rate 30 μL/s, sample volume 40 μL, UV detection at 270 nm for HTZ
and 290 nm for PRP.
Table 2 Application results of the SIC method to pharmaceutical formulations
Formulation Manufacturer Content (mg) Recovery
HTZ PRP HTZ PRP
Inderide
® tablets Wyeth Pharmaceuticals Inc. (Philadelphia, PA, US) 25 40 100.5 93.8
Inderide
® tablets Wyeth Pharmaceuticals Inc., (Philadelphia, PA, US) 25 80 97.0 104.9
Ciplar LA
® tablets Cipla Ltd. Mumbai Central (Mumbai, India) - 40 - 93.9
Lannett
® tablets Lannett Company Inc. (Philadelphia, PA, US) 25 - 100.3 -
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Page 6 of 8other hand, a new SIC method for the separation and
simultaneous quantification of PRP and HTZ in their
formulations was developed. A comparative study on
the efficiency of the proposed SIC method with previous
HPLC methods was conducted. The SIC method
recorded some advantages over the HPLC methods with
respect to rapidity, reagent consumption and safety for
the environment, besides the benefits of the instrumen-
tation of SIC over HPLC in terms of cost, portability,
operation procedure, stabilization time and maintenance
process.
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